Takeda will reorganize its executive leadership team and business structure effective April 1, 2026, as the company seeks to accelerate growth and decision-making amid a more complex global market. The Japanese drugmaker will create an International Business Unit to oversee all markets outside the U.S., consolidating commercial operations that had been managed separately. The Japan Pharma Business Unit will report through the new group for execution and financial planning, while remaining led...